Medical Genetics (MM)
Page 1: Introduction
Medical Genetics Lecture
Instructor: Matthew Machini, MD, MS
Institution: Nova Southeastern University Kiran C Patel College of Osteopathic Medicine, Clearwater, Florida
Page 2: Learning Objectives
Identify common features and examples of:
Autosomal Recessive
Autosomal Dominant
X-Linked Dominant
X-Linked Recessive
Recall specific genetic anomalies related to:
Autosomal recessive disorders: cystic fibrosis, sickle-cell anemia, Tay-Sachs disease.
Autosomal dominant disorders: Marfan syndrome, Huntington disease.
Define key terms:
Haploinsufficiency
Gain-of-function mutation
Dominant-negative mutation
Recall genetic anomalies tied to X-linked recessive disorders: Duchenne muscular dystrophy, hemophilia.
Page 3: Genetic Disease Transmission
Transmission patterns of single gene mutations:
Autosomal Dominant
Autosomal Recessive
X-linked
Page 4: Autosomal Dominant & Autosomal Recessive Transmission
I. Autosomal Dominant Characteristics
Equal affecting of males and females.
No carrier state exists.
Homozygous affected individuals are more severely affected than heterozygotes.
Phenotype appears in consecutive generations.
Children of affected parents have a 50% chance of being affected.
Normal phenotype individuals do not pass the allele to offspring.
Examples include Huntington's disease and Marfan syndrome.
II. Autosomal Recessive Characteristics
Equal affecting of males and females.
Carrier states exist.
Disease may skip generations.
Carriers have a 25% chance to produce an affected child.
Parental consanguinity may influence occurrence.
Examples include cystic fibrosis, sickle cell disease, and Tay-Sachs disease.
Page 5: X-Linked Transmission
III. X-Linked Dominant Characteristics
Females are usually more affected than males.
Affected males do not transmit their allele to sons.
Daughters of affected males are affected with a 50% chance of passing the mutant allele.
Examples include Rett syndrome and Fragile-X syndrome.
IV. X-Linked Recessive Characteristics
Most affected individuals are male.
Affected males transmit the gene only to daughters (carriers).
Sons of carrier females have a 50% chance of being affected; daughters have a 50% chance of being carriers.
Examples include Duchenne muscular dystrophy and hemophilia.
Page 6: List of Autosomal Dominant Disorders
Nervous System: Neurofibromatosis, Tuberous sclerosis, Huntington disease
Urinary System: Polycystic kidney disease
Gastrointestinal System: Familial polyposis coli
Hematopoietic System: Hereditary spherocytosis, Von Willebrand disease
Skeletal System: Marfan syndrome, Ehlers-Danlos syndrome, Osteogenesis imperfecta, Achondroplasia
Metabolic Disorders: Familial hypercholesterolemia
Page 7: List of Autosomal Recessive Disorders
Metabolic Disorders: Cystic fibrosis, Phenylketonuria, Galactosemia, Homocystinuria, Lysosomal storage diseases, Alkaptonuria
Hematopoietic Disorders: Sickle cell anemia, Thalassemia
Endocrine Disorders: Congenital adrenal hyperplasia
Nervous System Disorders: Friedreich ataxia, Spinal muscular atrophy
Page 8: Cystic Fibrosis (CF) Overview
CF is an autosomal recessive disease predominantly impacting exocrine glands, especially in lungs, liver, pancreas.
Epidemiology indicates 1 in 3900 births in the US have CF, with higher prevalence among Mediterranean and Ashkenazi Jewish populations.
Pathophysiology involves mutations in the CFTR gene located on chromosome 7 at locus q31.2, affecting chloride channels and leading to mucus accumulation and respiratory issues.
Five types of mutations exist regarding the functionality of CFTR protein.
Page 9: Cystic Fibrosis Carrier Inheritance
Carrier Risk: An unaffected carrier can pass on the CF allele; chance varies for their children (1 in 4 chance of having CF).
CF gene impacts multiple systems:
Lungs: Obstruction, infection risk.
Liver: Exocrine insufficiency, cirrhosis potential.
Pancreas: Diabetes and pancreatitis risks.
Intestine: Risk of meconium ileus and obstructions.
Page 10: Clinical Features of Cystic Fibrosis
Common Symptoms:
Recurrent pulmonary infections, chronic cough, poor growth, digestive issues, diabetes risk, male infertility (97% sterile).
Diagnosis: Genetic testing, newborn screening, sweat tests.
Treatment: Involves antibiotics, pulmonary therapy, gene therapy, and lung transplants.
Prognosis: Average life expectancy is 36.8 years.
Page 11: Sickle Cell Disease Varieties
Types include Hemoglobin SC, Hemoglobin S/beta thalassemia, Hemoglobin S/Lepore, Hemoglobin SO Arab.
Page 12: Overview of Sickle Cell Disease
Sickle cell disease is an autosomal recessive blood disorder affecting hemoglobin, characterized by sickle-shaped red blood cells.
Prevalence in the US is about 1 in 5000, predominantly affecting black individuals.
Clinical manifestations include sickle cell crisis, anemia, and organ damage.
Life expectancy ranges from 42 to 60 years.
Page 13: Geographical Distribution of Sickle Cell Anemia
Sickle cell trait carries evolutionary significance in malaria-endemic regions, providing survival advantages.
Page 14: Pathophysiology of Sickle Cell Disease
A mutation on chromosome 11 causes the substitution of valine for glutamic acid in hemoglobin.
Page 15: Detailed Pathophysiology
Abnormal hemoglobin promotes polymerization under low oxygen, leading to sickling of red blood cells and consequent occlusion of blood vessels.
Stressors like dehydration and high altitude can trigger sickle cell crises.
Page 16: Effects of Sickling on Blood Cells
Sickled cells can clog blood vessels, resulting in tissue ischemia and pain.
Page 17: Genetics of Sickle Cell Anemia
Inheritance is autosomal recessive; carriers may have minor symptoms if deprived of oxygen.
The gene responsible for sickle cell disease is located on the short arm of chromosome 11, specifically 11p15.5.
Page 18: Mechanism of Vascular Occlusion in Sickle Cell Disease
Sickle cell aggregates lead to increased adhesiveness in inflamed tissues and microvascular occlusion.
Page 19: Overview of Tay-Sachs Disease
A lysosomal storage disease prevalent among Ashkenazi Jews due to hexosaminidase A deficiency leading to GM2 ganglioside accumulation.
Symptoms include neurological deterioration and a characteristic cherry-red spot in the retina.
Page 21: Clinical Spectrum of Tay-Sachs Disease
Types of Tay-Sachs
Infantile Form: Onset in the first six months, leading to significant developmental decline by age 4-5.
Juvenile Form: Typically diagnosed between ages 2-10, with progressive deterioration.
Adult Onset: Less severe, presenting in 20s-30s with cognitive decline.
Page 22: Huntington Disease Overview
An autosomal dominant neurological disorder.
Prevalence: 1 in 10,000 with peak age of onset between 35-50 years.
Associated with CAG trinucleotide repeat expansions in the IT15 gene on chromosome 4.
Page 23: Neuroanatomy of Huntington Disease
Characteristic lateral ventricle enlargement and degeneration of the caudate nucleus and putamen.
Page 25: Mechanism of Neuron Death in Huntington Disease
Autophagy and nutrient starvation lead to neuron degradation.
Page 26: Involvement of Huntingtin Protein
Mutant huntingtin protein aggregation impairs cellular function and transcription.
Page 27: Implications of mHtt Aggregation
Accumulation of mutant huntingtin interferes with gene transcription and neurotrophic factors.
Page 28: Signs and Symptoms of Huntington Disease
Include chorea, dystonia, cognitive decline, and dysphagia.
Diagnosis and treatment focus on neurological exams and management of symptoms.
Page 29: Marfan Syndrome Overview
Genetic connective tissue disorder with autosomal dominant inheritance.
Characteristic features include tall stature and cardiovascular issues.
Page 30: Genetic Terminology in Autosomal Dominant Disorders
Haploinsufficiency: One normal allele is insufficient for the phenotype.
Gain-of-Function Mutation: Increased activity or expression of a gene.
Dominant-Negative Mutation: Mutant products negatively affect the normal protein.
Page 31: Mechanisms Related to Autosomal Dominant disorders
Discusses how various mutations influence disease progression and inheritance.
Page 32: Genetic Anomalies in X-Linked Recessive Disorders
Hemophilia A: Involves mutations in the F8 gene leading to impaired coagulation.
Page 33: Inheritance of Hemophilia
Affected fathers cannot pass the gene to sons but can to daughters, establishing carrier status.
Page 34: Overview of Duchenne Muscular Dystrophy
Genetic mutations lead to dystrophin absence causing muscle degeneration and clinical features.